- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 241/40 - Benzopyrazines
Détention brevets de la classe C07D 241/40
Brevets de cette classe: 68
Historique des publications depuis 10 ans
|
1
|
7
|
6
|
4
|
8
|
1
|
6
|
4
|
1
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1579 |
9 |
| Intra-Cellular Therapies, Inc. | 437 |
5 |
| Astex Therapeutics Limited | 207 |
3 |
| Development Center for Biotechnology | 146 |
3 |
| Platefuse, Inc. | 8 |
3 |
| Boehringer Ingelheim International GmbH | 4486 |
2 |
| Amgen Inc. | 4440 |
2 |
| Board of Regents, The University of Texas System | 6141 |
2 |
| Georgia Tech Research Corporation | 2963 |
2 |
| BP Oil International Limited | 72 |
2 |
| Sunovion Pharmaceuticals Inc. | 244 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3328 |
2 |
| Duke Street Bio Limited | 20 |
2 |
| F. Hoffmann-La Roche AG | 7808 |
1 |
| Roche Diagnostics GmbH | 2686 |
1 |
| Roche Diagnostics Operations, Inc. | 1522 |
1 |
| FUJIFILM Corporation | 30594 |
1 |
| Semiconductor Energy Laboratory Co., Ltd. | 11855 |
1 |
| Cheil Industries Inc. | 808 |
1 |
| The Regents of the University of Michigan | 5016 |
1 |
| Autres propriétaires | 22 |